Filing Details
- Accession Number:
- 0001127602-10-016345
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-06-03 13:00:00
- Reporting Period:
- 2010-06-01
- Filing Date:
- 2010-06-03
- Accepted Time:
- 2010-06-03 16:51:17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 729922 | Osi Pharmaceuticals Inc | OSIP | In Vitro & In Vivo Diagnostic Substances (2835) | 133159796 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1488772 | M. Angela Davies | C/O Osi Pharmaceuticals, Inc. 420 Saw Mill River Road Ardsley NY 10502 | Sr. Vp And Cmo, Oncology | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2010-06-01 | 298 | $57.44 | 5,436 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-06-03 | 445 | $57.50 | 4,991 | No | 4 | U | Direct | |
| Common Stock | Disposition | 2010-06-03 | 4,975 | $57.50 | 16 | No | 4 | D | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | U | Direct | |
| No | 4 | D | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2010-06-03 | 18,900 | $57.50 | 18,900 | $38.13 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2010-06-03 | 2,580 | $57.50 | 2,580 | $33.62 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2010-06-03 | 9,000 | $57.50 | 9,000 | $35.40 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2015-03-02 | No | 4 | D | Direct | |
| 0 | 2015-12-15 | No | 4 | D | Direct | |
| 0 | 2019-12-14 | No | 4 | D | Direct |
Footnotes
- Represents the number of unvested Restricted Stock Units that were canceled in exchange for a cash payment of $57.50 per unit in accordance with the Agreement and Plan of Merger, dated as of May 16, 2010, among OSI Pharmaceuticals, Inc., Astellas Pharma Inc., Astellas US Holding, Inc. and Ruby Acquisition, Inc.
- These stock options were canceled in exchange for a cash payment in accordance with the Agreement and Plan of Merger, dated as of May 16, 2010, among OSI Pharmaceuticals, Inc., Astellas Pharma Inc., Astellas US Holding, Inc. and Ruby Acquisition, Inc. The cash payment made with respect to each stock option equals the product of (x) the number of shares issuable upon the exercise of such option multiplied by (y) the excess, if any, of $57.50 over the exercise price per share for such option.
- Includes 16 shares acquired under the OSI Employee Stock Purchase Plan on June 1, 2010.
Billionaire Hedge Funds
